Abstract
Limited long term data exists regarding chronic total occlusion (CTO) revascularization with modern techniques and new-generation drug-eluting stents. EXPERT CTO ([NCT01435031][1]) is a prospective, multicenter registration trial examining the safety and effectiveness of XIENCE everolimus eluting
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.